Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Cornwell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|July 27, 2007
Investigating the mechanistic basis for hepatic toxicity induced by an experimental chemokine receptor 5 (CCR5) antagonist using a compendium of gene expression profilesPaul D Cornwell, Roger G Ulrich
Mutation Research|May 4, 2004
Profiling of hepatic gene expression in rats treated with fibric acid analogsPaul D Cornwell, Angus T De Souza, Roger G Ulrich
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 19, 2006
Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscleAngus T De Souza, Paul D Cornwell, Xudong Dai, et al.
Regulatory Toxicology and Pharmacology : RTP|July 5, 2024
Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetineRobert A Jolly, Paul D Cornwell, Jessica Noteboom, et al.
Chemical Research in Toxicology|May 28, 2024
Quantum Mechanical Assessment of Nitrosamine PotencySriman De, Bishnu Thapa, Fareed Bhasha Sayyed, et al.
International Journal of Toxicology|August 9, 2020
Drug Development 101: A PrimerLorrene A Buckley, Ilona Bebenek, Paul D Cornwell, et al.
Toxicologic Pathology|April 28, 2018
Pancreatic Effects of a Bruton's Tyrosine Kinase Small-molecule Inhibitor in Rats Are Strain-dependentManoj Bhaskaran, Paul D Cornwell, Steven D Sorden, et al.
The AAPS Journal|March 6, 2025
A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related ImpuritiesBrian W Pack, Robert W Siegel, Paul D Cornwell, et al.
Regulatory Toxicology and Pharmacology : RTP|October 25, 2025
Impurity qualification requirements for drug-linkers related impurities used to generate antibody-drug conjugatesOsama Chahrour, Paul D Cornwell, Penny Leavitt, et al.
Toxicologic Pathology|June 25, 2009
Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug developmentSteven K Engle, William H Jordan, Michael L Pritt, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|July 27, 2007
Investigating the mechanistic basis for hepatic toxicity induced by an experimental chemokine receptor 5 (CCR5) antagonist using a compendium of gene expression profilesPaul D Cornwell, Roger G Ulrich
Mutation Research|May 4, 2004
Profiling of hepatic gene expression in rats treated with fibric acid analogsPaul D Cornwell, Angus T De Souza, Roger G Ulrich
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 19, 2006
Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscleAngus T De Souza, Paul D Cornwell, Xudong Dai, et al.
Regulatory Toxicology and Pharmacology : RTP|July 5, 2024
Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetineRobert A Jolly, Paul D Cornwell, Jessica Noteboom, et al.
Chemical Research in Toxicology|May 28, 2024
Quantum Mechanical Assessment of Nitrosamine PotencySriman De, Bishnu Thapa, Fareed Bhasha Sayyed, et al.
International Journal of Toxicology|August 9, 2020
Drug Development 101: A PrimerLorrene A Buckley, Ilona Bebenek, Paul D Cornwell, et al.
Toxicologic Pathology|April 28, 2018
Pancreatic Effects of a Bruton's Tyrosine Kinase Small-molecule Inhibitor in Rats Are Strain-dependentManoj Bhaskaran, Paul D Cornwell, Steven D Sorden, et al.
The AAPS Journal|March 6, 2025
A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related ImpuritiesBrian W Pack, Robert W Siegel, Paul D Cornwell, et al.
Regulatory Toxicology and Pharmacology : RTP|October 25, 2025
Impurity qualification requirements for drug-linkers related impurities used to generate antibody-drug conjugatesOsama Chahrour, Paul D Cornwell, Penny Leavitt, et al.
Toxicologic Pathology|June 25, 2009
Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug developmentSteven K Engle, William H Jordan, Michael L Pritt, et al.
Pageof 1